- 专利标题： ANTI-GPRC5D ANTIBODY AND MOLECULE CONTAINING SAME
-
申请号： EP18750649.8申请日： 2018-02-06
-
公开(公告)号： EP3581651A1公开(公告)日： 2019-12-18
- 发明人: CHAEN, Takashi , OHTSUKA, Toshiaki , IIDA, Kenji , NAKAMURA, Kensuke , ABURATANI, Takahide , ICHIKAWA, Junya , KUDO, Shota , PISCITELLI, Chayne Lee , SANCHES, Mario
- 申请人： Daiichi Sankyo Company, Limited
- 申请人地址： 3-5-1, Nihonbashi Honcho Chuo-ku Tokyo 103-8426 JP
- 专利权人： Daiichi Sankyo Company, Limited
- 当前专利权人： Daiichi Sankyo Company, Limited
- 当前专利权人地址： 3-5-1, Nihonbashi Honcho Chuo-ku Tokyo 103-8426 JP
- 代理机构： Arends, William Gerrit
- 优先权： JP2017020220 20170207
- 国际公布： WO2018147245 20180816
- 主分类号： C12N15/09
- IPC分类号： C12N15/09 ; A61K39/395 ; A61P35/00 ; A61P35/02 ; C07K16/28 ; C07K16/46 ; C12N1/15 ; C12N1/19 ; C12N1/21 ; C12N5/10 ; C12P21/08
摘要：
[Problem to be Solved]
The present invention provides a novel antibody that binds to human GPRC5D, or a molecule having antigen binding activity, comprising the antibody.
[Solution]
The present invention provides a novel antibody that binds to human GPRC5D, a molecule having antigen binding activity, comprising the antibody, an anti-tumor pharmaceutical composition comprising the antibody or the molecule as an active ingredient, etc.
The present invention provides a novel antibody that binds to human GPRC5D, or a molecule having antigen binding activity, comprising the antibody.
[Solution]
The present invention provides a novel antibody that binds to human GPRC5D, a molecule having antigen binding activity, comprising the antibody, an anti-tumor pharmaceutical composition comprising the antibody or the molecule as an active ingredient, etc.
信息查询
IPC分类:
